Matthieu Ricard is one of the Buddhist monks that is most studied by Neuroscientists. His compassion meditation was contrasted with Indian breathing and mindfulness meditations by leading researchers. Matthieu joined Professor Steven Laureys for meditation and dialogue. Neurosteer monitored the brain activity during his compassion meditation, which looks very different from other meditations. We are excited to see a shift from multiple electrodes and fMRI to our single EEG channel.
The Parkinson Therapy Center in Brescia attracts patients from all over the world (many under 60) for a week of training to live with the disease. The neuropsychologists at the center are using Neurosteer’s frontal lobe cognitive assessment to suggest specific therapies to the different patients. Here is a short broadcast demonstrating this exciting project on Italian television.
Neurosteer started a clinical study at Langone Hospital, NYU with Prof. Leigh Charvet, on quantifying the effect of tDCS on Multiple Sclerosis (MS) patients. MS patients receive a frontal lobe stimulation to improve their cognition. Such stimulation is not always effective, and often patients receive 20 stimulation sessions to discover at the end that there was no effect. Neurosteer’s device will assess the effectiveness of the stimulation after one session and this will be correlated with the effect after 20 sessions. Such an assessment can provide an indication of the effectiveness of the treatment.
Neurosteer’s Nathan Intrator will discuss mobile brain sensing in clinical trials at the Neurotech conference at Stanford on February 26-27, 2018. Other speakers include DARPA’s Justin Sanchez; Kernel’s Bryan Johnson; Verily’s Brian Otis; Openwater’s Mary Lou Jepsen; and Khosla Ventures’ Vinod Khosla